scholarly journals Ferulic Acid Inhibits Catamenial Epilepsy Through Modulation of Female Hormones

Author(s):  
Harleen Kaur Dhillon ◽  
Tanveer Singh ◽  
Rajesh Kumar Goel

Abstract Approximately 40% of women with epilepsy experience perimenstrual seizure exacerbation, referred to as catamenial epilepsy. These seizures result from cyclic changes in circulating progesterone and estradiol levels and there is no effective treatment for this form of intractable epilepsy. We artificially increased progesterone levels and neurosteroid levels (pseudo-pregnancy) in adult Swiss albino female mice (19-23 g) by injecting them with pregnant mares' serum gonadotropin (5 IU s.c.), followed by human chorionic gonadotropin (5 IU s.c.) after 46 hours. After this, ferulic acid (25, 50, 100 mg/kg i.p.) treatment was observed for 10 days. During treatment, progesterone, estradiol, and corticosterone levels were estimated in blood on days 1, 5, and 10. Neurosteroid withdrawal was induced by finasteride (50 mg/kg, i.p.), a 5 α-reductase inhibitor on treatment day 9. Twenty-four hours after finasteride administration (day 10 of treatment), seizure susceptibility was evaluated with the sub-convulsant pentylenetetrazol (PTZ) dose (40 mg/kg i.p.). Four to six hours after PTZ, animals were assessed for depression like phenotypes using tail-suspension test (TST). Four to six hours following TST, animals were euthanized, and discrete brain parts (cortex and hippocampus) were separated for estimation of norepinephrine, serotonin, and dopamine as well as glutamic acid decarboxylase enzyme activity. PMSG and HCG treatment elevated progesterone and estradiol levels, assessed on days 1, 5, and 10 causing a state of pseudo-pregnancy. Treatment with finasteride increases seizure susceptibility and depression-like characteristics possibly due to decreased progesterone levels and elevated estrogen levels coupled with decreased monoamine and elevated corticosterone levels. Ferulic acid treatment, on the other hand, significantly decreased seizure susceptibility and depression like behaviours, possibly as a result of increased progesterone, restored estradiol, corticosterone, monoamine, and glutamic acid decarboxylase enzyme activity. We concluded that ferulic acid exhibited antiepileptic effects in a mouse model of catamenial epilepsy and comorbid depression due to its restorative effects on circulating hormones and cerebral monoamine and glutamic acid decarboxylase enzyme activity.

2016 ◽  
Vol 57 ◽  
pp. 282-290 ◽  
Author(s):  
Courtney L. Huff ◽  
Rachel L. Morano ◽  
James P. Herman ◽  
Bryan K. Yamamoto ◽  
Gary A. Gudelsky

1992 ◽  
Vol 70 (6) ◽  
pp. 922-925 ◽  
Author(s):  
N. Navarro Becerra ◽  
N. I. Munaro

Glutamic acid decarboxylase activity in the main and accessory olfactory bulbs throughout the sexual cycle of the rat was studied. The effect of male pheromonal secretion on enzyme activity during proestrus and estrus day was also tested. The enzyme activity showed circadian rhythm during the estrous cycle. This rhythm was disrupted during diestrus-2 afternoon in the main bulb and came back during proestrus afternoon. A different pattern of enzyme activity was present in the accessory bulb, since the circadian rhythm was altered during proestrus morning, returning during estrus afternoon. Male odor exposition did not change enzyme profile activity during proestrus day and during estrus morning in the main bulb. In contrast, in the accessory bulb the olfactory stimuli induced opposite changes to that found in rats from the vivarium during proestrus. Comparison of enzyme activity in olfactory stimuli-deprived rats with that of pheromone-stimulated rats during proestrus showed that male odor exposure specifically affects accessory bulb enzyme activity. It is concluded that the changes of the olfactory bulb GABAergic system during proestrus and estrus day, or that evoked by odor stimuli, demonstrate the discriminative response of this system between the accessory olfactory bulb and the main olfactory bulb.Key words: glutamic acid decarboxylase, pheromone, olfactory bulb, GABA, sexual cycle.


Diabetes ◽  
1993 ◽  
Vol 42 (4) ◽  
pp. 631-636 ◽  
Author(s):  
W. A. Hagopian ◽  
B. Michelsen ◽  
A. E. Karlsen ◽  
F. Larsen ◽  
A. Moody ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document